~~<i id='72933F7117'><strike id='72933F7117'><tt id='72933F7117'><pre id='72933F7117'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：entertainment 2025-09-27 13:02:48 - browse：284

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Scientists boost immune system in aging mice by making it youthful

knowledge

explore

leisure time

hotspot

focus

Wikipedia

DavidLRyan/GlobeStaffWhenVertexPharmaceuticalsmovedfromCambridgetoBoston’sSeaportadecadeago,itsignal

WSS

Covid vaccine financial winners and losers, from Pfizer to Novavax

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Supreme Court mifepristone arguments center on docs' right to sue

Decaf coffee targeted by food safety group under obscure FDA rule

FDA approves first treatment for ultra

Wikipedia

fashion

knowledge

Sports medicine is finally prioritizing gender equality

There's no autism epidemic. It's an autism diagnosis epidemic

Alkermes shareholders re

Patient advocates debate FDA's accelerated approval process

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

As demand for Covid shots wanes, Moderna seeks its next success

Washington mulls new rules to avert another Change Healthcare

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Majority of Americans think Trump's Ga. election interference case is serious: POLL

explore

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Study says nonprofit hospitals fall short in charity care spending

Liz Cheney makes 1st public comment since Trump's election interference indictments

Clinical trials must include more disabled people

Hilary expected to bring catastrophic, life

Ukraine taking heavy casualties 10 weeks into its counteroffensive

leisure time

hotspot

focus

Wikipedia